Brigham and Women's Hospital
Boston, Massachusetts, 02215, United States
NCT Number: NCT03234933
This research study is evaluating the postoperative results in terms of quality of life and functional recovery of elderly patients after cancer surgery.
Looking for future studies?
Notify MeThis is a pilot study, designed to collect data on steps walked (ambulation) per day of lobectomy patients after surgery. While the investigators know ambulation improves outcomes after surgery, there is no institutional policy, set of patient goals, or method for deciding which patients require further resources, such as physical therapy. Data collected will be used to set up a hospital-wide strategy for patients to achieve post-operative ambulation milestones more readily.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Tracking Patient's movements and calories
Time frame: 2 years
Number of steps taken by subjects will be recorded on a mobility tracker, starting at the time of admission to the floor and ending at the time of discharge.
Time frame: 2 years
The distance walked by subjects will be recorded on a mobility tracker, starting at the time of admission to the floor and ending at the time of discharge.
Time frame: 2 years
The number of calories burned by subjects will be recorded on a mobility tracker, starting at the time of admission to the floor and ending at the time of discharge.
Dana-Farber Cancer Institute
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01498276
Cancer, Cardiovascular Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT04746859
Cancer, Chronic Disease
Barrie, Ontario, Canada
View Trial DetailsNCT02517281
Cancer, Neoplasms
Villejuif, Val de Marne, France
View Trial DetailsNCT00180869
Cancer, Neoplasms
Villejuif, France
View Trial Details